Abstract

AimOur aim was to evaluate the accuracy of aerobic exercise testing to diagnose metabolic myopathies.MethodsFrom December 2008 to September 2012, all the consecutive patients that underwent both metabolic exercise testing and a muscle biopsy were prospectively enrolled. Subjects performed an incremental and maximal exercise testing on a cycle ergometer. Lactate, pyruvate, and ammonia concentrations were determined from venous blood samples drawn at rest, during exercise (50% predicted maximal power, peak exercise), and recovery (2, 5, 10, and 15 min). Biopsies from vastus lateralis or deltoid muscles were analysed using standard techniques (reference test). Myoadenylate deaminase (MAD) activity was determined using p-nitro blue tetrazolium staining in muscle cryostat sections. Glycogen storage was assessed using periodic acid-Schiff staining. The diagnostic accuracy of plasma metabolite levels to identify absent and decreased MAD activity was assessed using Receiver Operating Characteristic (ROC) curve analysis.ResultsThe study involved 51 patients. Omitting patients with glycogenoses (n = 3), MAD staining was absent in 5, decreased in 6, and normal in 37 subjects. Lactate/pyruvate at the 10th minute of recovery provided the greatest area under the ROC curves (AUC, 0.893 ± 0.067) to differentiate Abnormal from Normal MAD activity. The lactate/rest ratio at the 10th minute of recovery from exercise displayed the best AUC (1.0) for discriminating between Decreased and Absent MAD activities. The resulting decision tree achieved a diagnostic accuracy of 86.3%.ConclusionThe present algorithm provides a non-invasive test to accurately predict absent and decreased MAD activity, facilitating the selection of patients for muscle biopsy and target appropriate histochemical analysis.

Highlights

  • Myalgia and exercise intolerance are common complaints in clinical practice

  • Lactate/pyruvate at the 10th minute of recovery provided the greatest area under the Receiver Operating Characteristic (ROC) curves (AUC, 0.893 ± 0.067) to differentiate Abnormal from Normal Myoadenylate deaminase (MAD) activity

  • The resulting decision tree achieved a diagnostic accuracy of 86.3%

Read more

Summary

Introduction

Myalgia and exercise intolerance are common complaints in clinical practice. The symptoms may represent inflammatory myopathies, muscular dystrophies, congenital myopathies and metabolic myopathies, as well as non-myopathic conditions. Exercise increases the concentrations of muscle metabolites in the venous blood supply (e.g. lactate, pyruvate, and ammonia), especially during recovery [7,10]. Venous blood sampling during and after exercise is an easy method to provide information about muscle metabolism. The determination of lactate concentrations at rest or following exercise has been proposed as a diagnosis tool [6,7,8,11]. Few studies have evaluated the diagnostic accuracy of incremental exercise testing to investigate metabolic myopathies [6,11]. To assess the validity of this approach, we evaluated metabolic parameters of blood sampled during and after CPX against the reference standard, i.e. muscle biopsy, in order to develop an intuitive non-invasive diagnostic algorithm for metabolic myopathies. To fine-tune the accuracy of our decision tree, we used Receiver Operating Characteristic (ROC) curve analysis to validate each node of the decision tree and to determine cut-off values [21,22,23,24,25,26]

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.